Page 5 - Stock Market

India's equity markets, economy: Will investors update their beliefs?

The Nifty is a club of giants - banks, financiers, software firms, pharmaceuticals, consumer staples, and commodity producers

Would like to build Unity Bank before IPO to create best value: Bindra

Centrum Group Chief Jaspal Bindra outlines unity bank's expansion strategy, universal bank ambitions and IPO timeline, alongside plans for portfolio diversification and capital strength

Hong Kong, India drive Asia's blockbuster year for equity fundraising

The upswing has been broad-based across Asia. Four of the world's five largest share-sale venues are in the continent, with India, mainland China and Japan trailing Hong Kong

Sebi faces privacy hurdles over asset disclosure proposal, says Chairman

SEBI officials are questioning the need for such disclosures, noting they are not mandated for any other authority in India, Pandey added

Mkt regulator Sebi clears Pranav Adani, others of insider trading charges

In a separate 63-page order, Sebi also dropped insider trading charges against Vinod Bahety, former head of M&A at the Adani Group, and three associated entities

KSH International IPO opens Dec 16; key risks, strengths you must know

KSH International IPO will be offered at a price band of ₹365 to ₹384 per share and the lot size has been set at 39 shares

Wakefit Innovations IPO allotment today; check status, GMP, listing date

Applicants can check their Wakefit Innovations IPO allotment status on the official websites of NSE and BSE, or the registrar Kfin Technologies

ICICI Prudential AMC IPO opens Dec 12: 5 key strengths investors must know

ICICI Prudential IPO will be offered at a price band of ₹2,061 to ₹2,165 per share, with a lot size of 6 shares

Aequs lists at 13% premium; analysts flag upside with caution; find out why

Analysts suggest investors to hold for long term, citing the company's strong positioning as one of India's most advanced aerospace precision-manufacturing platforms

What’s dragging Indian stocks to their worst global ranking in 3 decades?

Indian equities are having their worst year against global peers in over three decades. As foreign money exits and global investors chase China and AI-linked stocks

Nephrocare Health IPO opens Dec 10: Should you bid? Here's what experts say

Nephrocare Health IPO comprises a fresh issue of 7.7 million, amounting to ₹353.4 crore and an offer for sale (OFS) of 11.3 million equity shares amounting to ₹517.64 crore

Motilal Oswal sector of the week: Defence; check top bets, target here

According to Motilal Oswal, defence electronics continues to see long-term demand for radars, avionics, communication systems and electronic warfare solutions

Mutual funds and equities fastest-growing asset classes, says report

Yet India's household allocation remains far below US, UK, Canada

Wakefit Innovations IPO opens today: Check GMP, price band, dates, review

Ahead of its IPO, Wakefit Innovations raised ₹580 crore from 33 institutional investors via an anchor book on December 5

Near-term lag, long-term leadership: India's market story endures

Samir Arora says India's policy stability, improving earnings and rising domestic flows leave no structural reason for global investors to stay underweight

Senior IRS officer Sandip Pradhan takes charge as Sebi whole-time member

Pradhan, a 1990-batch IRS officer, was until recently director general of income tax (investigation) in Pune, where he handled major tax investigations and compliance enforcement

Park Medi World IPO opens Dec 10; sets price band at ₹154-162: Key details

Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore

Largecaps to outperform in 2026 as SMID valuations look stretched: BofA Sec

Bank of America (BofA) Securities said it continues to prefer largecaps over small and midcaps (SMIDs) in CY26 as valuations remain elevated and risks are skewed to the downside

Corona Remedies IPO opens Dec 8: GMP at 31%; 5 key risks you should know

Corona Remedies IPO will be offered at a price band of ₹1,008 to ₹1,062 per share, with a lot size of 14 shares

Largecaps to outperform in 2026 as SMID valuations look stretched: BofA

Bank of America (BofA) Securities said it continues to prefer largecaps over small and midcaps (SMIDs) in CY26 as valuations remain elevated and risks are skewed to the downside